Table 3.
Pathological and oncological outcomes
| Variable | Data (n = 124) |
|---|---|
| Pathological T stage | |
| T0 | 17 (13.7) |
| T1/2 | 9 (7.3) |
| T3 | 42 (33.9) |
| T4 | 56 (45.2) |
| Pathological N stage | |
| 0 | 74 (59.7) |
| 1 | 35 (28.2) |
| 2 | 15 (12.1) |
| Nodal yield | 15.5 (0–66) |
| Extranodal extension | 17 (13.7) |
| Lymphovascular invasion | 24 (19.4) |
| Perineural invasion | 23 (18.5) |
| Tumor regression grade (n = 113) | |
| 1 | 17 (15.0) |
| 2 | 24 (21.2) |
| 3 | 32 (28.3) |
| 4 | 32 (28.3) |
| 5 | 8 (7.1) |
| Pathological complete response (n = 116) | 12 (10.3) |
| Positive CRM (R1 resection); 95% CI | 9 (7.3); 3.4%–13.4% |
| Adjuvant chemotherapy | 87 (70.1) |
Values are presented as number (%) and median (range) unless otherwise specified.
CRM, circumferential resection margin.